MicardisPlus 80 mg/25 mg tablets

Company
Boehringer Ingelheim Limited
Active Ingredient
Dosage Form
Tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/02/213/17 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/18 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/19 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/20 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/21 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/22 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
EU/1/02/213/23 80 mg/25 milligram(s) C09DA, C09DA07 Tablet
Licence number
EU/1/02/213/17
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/18
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/19
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/20
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/21
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/22
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet
Licence number
EU/1/02/213/23
Strength
80 mg/25 milligram(s)
ATC Code
C09DA, C09DA07
Dosage Form
Tablet

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9

Email
medinfo.ukie@boehringer-ingelheim.com